跳至主要内容
临床试验/IRCT20200428047229N2
IRCT20200428047229N2招募中3 期

The efficacy of compound honey syrup on Fractional exhalation Nitric Oxide (FeNO) changes in Cystic Fibrosis patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 no limit(—)
性别
All

入选标准

  • All cystic fibrosis patients over 6 years of age should be referred to the pulmonary clinic of Mofid Children's Hospital, diagnosed by a pediatric lung specialist.
  • Conscious consent of parents of children and children over 6 years of age

排除标准

  • Cystic fibrosis patients under 6 years of age referred to the pulmonary clinic of Mofid Children's Hospital
  • Patients in need of hospitalization
  • Patients who have attack symptoms of the disease (increased cough, sputum, fever, and need for hospitalization).
  • Patients with underlying diseases such as allergic bronchopulmonary aspergillosis, heart failure and tuberculosis.
  • Patients with other acute illnesses during treatment.
  • Patients who are allergic to any of the components of the compound honey syrup.
  • Patients who have decided to leave the study at their own request.
  • Patients who are unable to co-operate with the FeNO test.

研究者

相似试验